Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2771-2024Class II

Centurion procedure kits, labeled as: 1) BREAST BIOPSY KIT, Pack Number MNS6950A; 2) BREAST BIOPSY PACK, Pack...

MEDLINE INDUSTRIES, LP - Northfield / initiated 2024-04-08 / Open, Classified

MEDLINE INDUSTRIES, LP - Northfield began a recall of Centurion procedure kits, labeled as: 1) BREAST BIOPSY KIT, Pack Number MNS6950A; 2) BREAST BIOPSY PACK, Pack number BT515A on . FDA classified it as Class II and gives the reason as "Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/ other quality issues have been identified that may pose a risk to patient health". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-2771-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
MEDLINE INDUSTRIES, LP - Northfield
Product
Centurion procedure kits, labeled as: 1) BREAST BIOPSY KIT, Pack Number MNS6950A; 2) BREAST BIOPSY PACK, Pack number BT515A
Product code
PXP Breast Biopsy / Localization Tray
Reason for recall
Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/ other quality issues have been identified that may pose a risk to patient health.
FDA root cause
Under Investigation by firm
Action
Medline Industries LP issued a recall notice to its consignees on 04/08/2024 via letter delivered via USPS and email. The notice explained the issue, provided a link to for information pertaining to the risk involved https://www.fda.gov/medical-devices/safety-communications/update-evaluating-plastic-syringes-made-china-potential-device-failures-fda-safety-communication) and request that the syringes within the convenience be discarded, except for circumstances where no alternative syringes are readily available. If these syringes must be used, closely monitor for leaks, breakage, and any other problems, and report any quality issues to Medline and the FDA. Distributors were directed to notify their customers. The firm issued a second recall notice (an expansion) on 05/02/2024 using the same methods.
Distribution
worldwide
Product codes and lots
MNS6950A, Lot Number 2018101150; MNS6950A, Lot Number 2019022550; MNS6950A, Lot Number 2019040350; BT515A, Lot Number 2020040990; BT515A, Lot Number 2021062990; BT515A, Lot Number 2022012090; BT515A, Lot Number 2022022890; BT515A, Lot Number 2022072990; BT515A, Lot Number 2022103190; BT515A, Lot Number 2023031790; BT515A, Lot Number 2023032890; BT515A, Lot Number 2023072590; BT515A, Lot Number 2024022990;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2771-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2766-2024Class IIOngoingVoluntary: Firm initiated
Z-2767-2024Class IIOngoingVoluntary: Firm initiated
Z-2768-2024Class IIOngoingVoluntary: Firm initiated
Z-2769-2024Class IIOngoingVoluntary: Firm initiated
Z-2770-2024Class IIOngoingVoluntary: Firm initiated
Z-2771-2024Class IIOngoingVoluntary: Firm initiated
Z-2772-2024Class IIOngoingVoluntary: Firm initiated
Z-2773-2024Class IIOngoingVoluntary: Firm initiated